XML 21 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Retained Earnings
Beginning balance, common stock (in shares) at Mar. 31, 2022   54,430,000        
Beginning balance at Mar. 31, 2022 $ 1,577,611 $ 544 $ 515,583 $ (133,648) $ (19,032) $ 1,214,164
Beginning balance, treasury stock (in shares) at Mar. 31, 2022       4,151,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation $ 12,405   12,405      
Exercise of stock options (in shares) 205,200 205,000        
Exercise of stock options $ 7,372 $ 2 7,370      
Issuance of shares related to restricted stock (in shares)   222,000        
Issuance of shares related to restricted stock 0 $ 2 (2)      
Treasury share repurchases (in shares)       1,014,000    
Treasury share repurchases (55,466)     $ (55,466)    
Net income (loss) (82,306)         (82,306)
Other comprehensive loss (12,532)       (12,532)  
Ending balance, common stock (in shares) at Mar. 31, 2023   54,857,000        
Ending balance at Mar. 31, 2023 1,447,084 $ 548 535,356 $ (189,114) (31,564) 1,131,858
Ending balance, treasury stock (in shares) at Mar. 31, 2023       5,165,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation $ 14,010   14,010      
Exercise of stock options (in shares) 440,300 441,000        
Exercise of stock options $ 18,089 $ 5 18,084      
Issuance of shares related to restricted stock (in shares)   203,000        
Issuance of shares related to restricted stock 0 $ 2 (2)      
Treasury share repurchases (in shares)       515,000    
Treasury share repurchases (30,507)     $ (30,507)    
Net income (loss) 209,339         209,339
Other comprehensive loss (2,931)       (2,931)  
Ending balance, common stock (in shares) at Mar. 31, 2024   55,501,000        
Ending balance at Mar. 31, 2024 $ 1,655,084 $ 555 567,448 $ (219,621) (34,495) 1,341,197
Ending balance, treasury stock (in shares) at Mar. 31, 2024 5,680,000     5,680,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation $ 11,157   11,157      
Exercise of stock options (in shares) 303,400 303,000        
Exercise of stock options $ 14,802 $ 3 14,799      
Issuance of shares related to restricted stock (in shares)   206,000        
Issuance of shares related to restricted stock 0 $ 2 (2)      
Treasury share repurchases (in shares)       821,000    
Treasury share repurchases (57,587)     $ (57,587)    
Net income (loss) 214,605         214,605
Other comprehensive loss (3,164)       (3,164)  
Ending balance, common stock (in shares) at Mar. 31, 2025   56,010,000        
Ending balance at Mar. 31, 2025 $ 1,834,897 $ 560 $ 593,402 $ (277,208) $ (37,659) $ 1,555,802
Ending balance, treasury stock (in shares) at Mar. 31, 2025 6,501,000     6,501,000